A coalition of public health organizations, a pediatrician, and parents whose children developed nicotine addictions filed a federal lawsuit on July 14 challenging FDA guidance issued in May that allows electronic nicotine delivery systems and oral nicotine pouches to be sold without completing the premarket authorization process the agency is legally required to apply to tobacco products.
The lawsuit was filed in the United States District Court for the District of Maryland and argues that the guidance exceeds the FDA’s statutory authority and amounts to a deliberate abdication of the agency’s responsibilities under federal tobacco law. Plaintiffs include several of the country’s largest public health advocacy organizations alongside individuals directly affected by youth nicotine addiction.
What the FDA guidance did and why plaintiffs say it is unlawful
Federal law generally requires manufacturers of tobacco products to obtain premarket authorization before their products can be legally sold in the United States. This process, known as a premarket tobacco product application, requires manufacturers to submit scientific data demonstrating that their product is appropriate for the protection of public health, a standard the FDA reviews before granting authorization.
The May guidance stated that for electronic nicotine delivery systems, including e-cigarettes and vape pens, and for oral nicotine pouches, the FDA would generally not prioritize enforcement of the premarket authorization requirement. The agency made this exemption conditional, applying it where a manufacturer has already submitted an application that the FDA has accepted and filed but not yet fully reviewed.
Plaintiffs argue this creates a meaningless standard. An application being accepted and filed by the FDA does not involve any substantive scientific assessment of the product or evaluation of its public health implications. It is an administrative step that precedes actual review, not a substitute for it. Under the guidance, products sitting in a queue waiting for review that may never come can effectively remain on the market indefinitely without the scientific scrutiny that premarket authorization is designed to provide.
Who is suing and why their standing matters
The plaintiffs include the Campaign for Tobacco-Free Kids, the American Academy of Pediatrics, the American Cancer Society Cancer Action Network, the American Heart Association, the American Lung Association, the Truth Initiative, and Parents Against Vaping E-Cigarettes. A pediatrician who treats young patients experiencing nicotine addiction and a parent whose child became addicted to flavored e-cigarettes are also named as plaintiffs, providing the lawsuit with both institutional and individual standing that strengthens the case for federal court jurisdiction.
The inclusion of a pediatrician and a parent reflects a deliberate litigation strategy of grounding abstract regulatory arguments in concrete human consequences. Youth nicotine addiction driven by flavored e-cigarette products has been documented extensively in public health research, and the FDA’s premarket authorization requirement was specifically designed to prevent new nicotine products from reaching young consumers without scientific review of their public health risks.
What the lawsuit is asking the court to do
The plaintiffs are asking the court to strike down the May guidance as unlawful, which would require the FDA to enforce its premarket authorization requirements against electronic nicotine delivery systems and oral nicotine pouches that have not completed the full review process. If successful, the lawsuit could force a significant number of products off the market while their applications are pending or result in accelerated review timelines to avoid enforcement.
The FDA had not commented publicly on the lawsuit at the time of filing. The May guidance represented a significant policy shift for the agency and generated immediate criticism from public health advocates who argued that it effectively surrendered regulatory control over a category of products that has been associated with substantial youth addiction rates since flavored vaping products became widely available.
